CC
CSTL icon

Corton Capital’s Castle Biosciences CSTL Stock Holding History

Corton Capital’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,302
Closed -$322K – 439
2024
Q3 		$322K Sell
11,302
-969
-8% -$24.7K 0.16% 166
2024
Q2 		$267K Buy
12,271
+1,148
+10% +$25.6K 0.14% 233
2024
Q1 		$246K Sell
11,123
-1,220
-10% -$26.5K 0.09% 339
2023
Q4 		$266K Buy
+12,343
New +$217K 0.08% 363

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Corton Capital's CSTL Position: Q4 2024 in Review

Corton Capital sold out of Castle Biosciences (CSTL) in Q4 2024, closing a stake of 11,302 shares — an estimated $322K sold.

Corton Capital first reported a position in CSTL in Q4 2023 and held it in 4 quarters. The position peaked at $322K in Q3 2024. 197 funds tracked by Wall St. Rank hold CSTL as of Q4 2024.

  • Corton Capital reported no remaining Castle Biosciences position as of Q4 2024 after selling out during the quarter.
  • Corton Capital sold 11,302 Castle Biosciences shares in Q4 2024, an estimated $322K.
  • Corton Capital first reported a position in Castle Biosciences in Q4 2023 and held it in 4 quarters.
  • Corton Capital's Castle Biosciences position peaked at $322K in Q3 2024.
  • 197 funds tracked by Wall St. Rank held Castle Biosciences as of Q4 2024.

Based on Corton Capital's 13F filing for Q4 2024, filed 14 Feb 2025.